SCHEMBL125385

SCHEMBL125385

Cc1cccc(NC(C)O)c1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
TDP1 Q9NUW8 2/20 0.56
TSHR P16473 4/20 0.50
KAT2B Q92831 1/20 0.50
HPGD P15428 3/20 0.42
POLB P06746 2/20 0.42
KMT2A Q03164 4/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
MEN1 O00255 3/20 0.40
LMNA P02545 2/20 0.39
DDX3X O00571 1/20 0.39
CYP3A4 P08684 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
MITF O75030 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24455476 0.87 ALDH1A1 (0.60) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL18037665 0.84 GPR35 (0.50) ALDH1A1TDP1TSHRKAT2BPOLB
SCHEMBL27940262 0.80 ALDH1A1 (0.64) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL3384697 0.79 ALDH1A1 (0.47) ALDH1A1TSHRKAT2BHPGDKMT2A
SCHEMBL19899520 0.78 ALDH1A1 (0.67) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL16831668 0.77 ALDH1A1 (0.60) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL2045312 0.77 HCAR3 (0.38) ALDH1A1TDP1MAPTSMN1; SMN2LMNA
SCHEMBL16831666 0.77 ALDH1A1 (0.60) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL28204059 0.76 ALDH1A1 (0.64) ALDH1A1TDP1TSHRKAT2BHPGD
SCHEMBL11620684 0.75 ALDH1A1 (0.58) ALDH1A1TDP1TSHRKAT2BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2158942-A2 Direct hair dye composition comprising insoluble oxygenated compounds and processes L'Oreal (FR) 2010-03-03 EP claimed
US-7651534-B2 Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition L'OREAL SA (FR) 2010-01-26 US claimed
EP-1757326-B1 Direct dying composition comprising insoluble oxygenated compounds and processes OREAL (FR) 2009-01-07 EP claimed
US-20070044251-A1 Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition L'OREAL S.A. (FR) 2007-03-01 US claimed
EP-1757326-A1 Direct dying composition comprising insoluble oxygenated compounds and processes L'Oréal (FR) 2007-02-28 EP claimed
EP-1430876-A1 Composition containing a direct dyestuff and a specific polymer for colouring of keratinic fibres, method for the preparation thereof and process of dyeing with such a composition L'OREAL (FR) 2004-06-23 EP claimed
CN-119403534-A Method for treating keratin fibres comprising a pretreatment or post-treatment step 莱雅公司 2025-02-07 CN disclosed
CN-119403533-A Method for treating keratin fibres using a carnitine salt or a carnitine derivative 莱雅公司 2025-02-07 CN disclosed
CN-118043027-A Process for dyeing and/or lightening keratin fibres 莱雅公司 2024-05-14 CN disclosed
EP-4362892-A1 COMPOSITION COMPRISING AT LEAST ONE ALKYL (POLY)GLYCOSIDE, AT LEAST ONE FATTY ALCOHOL, AT LEAST ONE FATTY ACID, AND AT LEAST ONE ALKALINE AGENT L'OREAL (FR) 2024-05-08 EP disclosed
EP-4362896-A1 COMPOSITION COMPRISING N,N-DICARBOXYMETHYLGLUTAMIC ACID, 1,3-PROPANEDIOL, AT LEAST ONE NONIONIC SURFACTANT, AT LEAST ONE ALKALINE AGENT AND/OR AT LEAST ONE DYE L'OREAL (FR) 2024-05-08 EP disclosed
EP-4362906-A1 COMPOSITION COMPRISING SHEA, AN ALKYL(POLY)GLYCOSIDE, A POLYSACCHARIDE AND A DYE L'OREAL (FR) 2024-05-08 EP disclosed
CN-117479916-A Composition comprising at least one alkyl (poly) glycoside, at least one fatty alcohol, at least one fatty acid and at least one alkaline agent 欧莱雅 2024-01-30 CN disclosed
EP-1380820-A1 Procedure of determining the composition of a dyeing product L'OREAL S.A. (FR) 2004-01-14 EP disclosed
US-20030152534-A1 Composition for dyeing keratin fibers comprising a particular aminosilicone L'OREAL S.A. (FR) 2003-08-14 US disclosed
US-20030140429-A1 Keratin fibre dyeing composition comprising a particular aminosilicone L'OREAL S.A. (FR) 2003-07-31 US disclosed
US-20030106169-A1 Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye L'OREAL S.A. (FR) 2003-06-12 US disclosed
EP-1312344-A2 Dyeing composition for keratinous fibres containing aminosilicone L'OREAL (FR) 2003-05-21 EP disclosed
EP-1312343-A2 Dyeing composition for keratinous fibres containing aminosilicone L'OREAL S.A. (FR) 2003-05-21 EP disclosed
EP-1297819-A2 Composition for dyeing keratinous fibres comprising a cationic azo dye L'OREAL (FR) 2003-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030106169-A1 Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye KRT18, TUBB3, TUBB1 ALDH1A1 2065/4885TDP1 3973/4885TSHR 4818/4885
US-20070044251-A1 Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition KRT18, DSG1, PLOD2 ALDH1A1 188/4885TDP1 1969/4885TSHR 4670/4885
US-20030152534-A1 Composition for dyeing keratin fibers comprising a particular aminosilicone KRT18, TUBB8, TUBA8 ALDH1A1 1914/4885TDP1 4255/4885TSHR 4575/4885
US-20030140429-A1 Keratin fibre dyeing composition comprising a particular aminosilicone KRT18, TUBB3, TUBA3E ALDH1A1 1615/4885TDP1 2678/4885TSHR 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.